DTE vs INMB
DTE (DTE) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
DTE does not have a complete income-statement cache yet.
Latest reported INMB revenue for 2024-12-31 was $14.0K. Net income was -$42.1M. Revenue was down 91.0% from 2023-12-31 to 2024-12-31. INMB currently screens at market cap $33.5M.
DTE currently screens at market cap $0. INMB currently screens at market cap $33.5M.
Not investment advice. Open the DTE and INMB stock pages for the full models.
Not investment advice.